Reply: Diagnostic accuracy of ChatGPT-4 and liver fibrosis in MASH [0.03%]
回复：ChatGPT-4在MASH肝纤维化诊断准确性中的应用
Davide Panzeri,Luca Di Tommaso,Laura Sironi
Davide Panzeri
Letter to the Editor: "Diagnostic accuracy of ChatGPT-4 and liver fibrosis in MASH" [0.03%]
读者来信：“ChatGPT-4在MASH肝纤维化诊断中的准确性”
Amnuay Kleebayoon,Viroj Wiwanitkit
Amnuay Kleebayoon
Hepatocyte-derived Pumilio1-enriched exosomes inhibit HSC activation by suppressing tropomyosin-4 translation [0.03%]
肝细胞源性富集Pumilio1的外泌体通过抑制肌钙蛋白4翻译抑制肝星状细胞活化
Zhiping Wan,Xiang Cai,Xiaoquan Liu et al.
Zhiping Wan et al.
Background: Metabolic dysfunction-associated steatotic liver disease (MASLD) has become the most common chronic liver disease globally. Abnormal crosstalk between hepatocytes and HSCs leads to liver fibrosis and aggravate...
Educational, financial, logistical, emotional, and social needs among patients with hepatocellular carcinoma [0.03%]
肝细胞癌患者的教育、经济、后勤、情感和社会需求
Debbiesiu L Lee,Sophia Hon,Daniela Prieto Bello et al.
Debbiesiu L Lee et al.
Background: Patient navigation has been proposed as a primary method of facilitating successful treatment and outcomes for cancer patients. In order to design a navigation program specific for HCC patients, the aims of th...
Long-term outcomes after ICU admission in critically ill patients with liver cirrhosis: An Australian state-wide cohort study [0.03%]
肝硬化危重患者入住重症监护病房后的长期结局：一项全州范围队列研究
Danny Con,William Kemp,Avik Majumdar et al.
Danny Con et al.
Background: Patients with liver cirrhosis requiring intensive care unit (ICU) admission have a high in-hospital mortality, yet long-term mortality and predictors of mortality in survivors remain unknown. ...
The incidence and predictors of false-negative pancreatobiliary fluorescence in situ hybridization (PB-FISH) in biliary strictures: A prospective study [0.03%]
胆管狭窄胰胆池内染色体杂交假阴性的发生率及预测因素：一项前瞻性研究
Manik Aggarwal,Gregory J Gores,Eric J Vargas et al.
Manik Aggarwal et al.
Background: Fluorescence in situ hybridization (FISH) is recommended as part of multimodality sampling in the evaluation of biliary strictures, but can be false negative in 40%-50% cases. The aim of this study was to comp...
Rethinking FIB-4: The hidden zonal bias in alpha-1 antitrypsin deficiency [0.03%]
再思考FIB-4：α1抗胰蛋白酶缺乏症的隐性区带偏差
Mohammed Abdulrasak
Mohammed Abdulrasak
Predictors of response to terlipressin therapy in hepatorenal syndrome: Metabolomic and proteomic analysis from the CONFIRM trial [0.03%]
代谢组学和蛋白质组学分析：来自CONFIRM试验的肝肾综合征患者特利压林治疗反应预测因素研究
Andrew S Allegretti,Josh Levitsky,Pratima Sharma et al.
Andrew S Allegretti et al.
Background: Terlipressin is the only FDA-approved vasoconstrictor for hepatorenal syndrome (HRS). The CONFIRM study is the largest trial of terlipressin versus placebo. Novel predictors of HRS response are required to enr...
Randomized Controlled Trial
Hepatology communications. 2025 Jul 14;9(8):e0766. DOI:10.1097/HC9.0000000000000766 2025
Communication initiated by hepatocytes: The driver of HSC activation and liver fibrosis [0.03%]
肝细胞启动的信号通路：活化HSC和促进肝纤维化的主导因素
Ruichao Lan,Jun Lin,Shuai Chen et al.
Ruichao Lan et al.
Liver fibrosis (LF) refers to the excessive deposition and abnormal distribution of the extracellular matrix (ECM) caused by acute or chronic liver injury, which affects the prognosis of liver diseases. Activated HSCs play a central role in...
CRISPR-mediated proximity labeling unveils ABHD14B as a host factor to regulate HBV cccDNA transcriptional activity [0.03%]
基于CRISPR的邻近标记技术揭示ABDH14B通过调节HBV cccDNA转录活性发挥宿主作用
Kazuma Sekiba,Nozomi Miyake,Yu Miyakawa et al.
Kazuma Sekiba et al.
Background: The long-term goal of chronic hepatitis B research is a functional cure (HBsAg seroclearance). Although currently used nucleos(t)ide analogs can efficiently inhibit viral replication, they do not reduce viral ...